lorcaserin HCl

Eisai Has Announced The Availability of Belviq (Lorcaserin HCl) CIV Tablets in The US
Jun 13, 2013
Eisai has announced the availability of Belviq (lorcaserin HCl) CIV tablets in the US, which is designed for chronic weight management in adults who are overweight with a comorbidity or obesity. Indicated for people with body mass ...

Tags: Eisai, Weight Management Therapy
Eisai Laboratorios Has Submitted a Marketing Authorization Application for Belviq
Apr 3, 2013
Eisai's subsidiary Eisai Laboratorios has submitted a marketing authorization application (MAA) for Belviq (lorcaserin HCl) with the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico. Arena Pharmaceuticals's ...

Tags: Eisai, Mexican Marketing, Belviq
Arena Pharmaceuticals and Eisai Have Announced FDA Approval of Belviq
Dec 5, 2012
Arena Pharmaceuticals and Eisai have announced FDA approval of Belviq (lorcaserin HCl) for chronic weight management in adults who are overweight with comorbidity or obese. The FDA approved Belviq as an adjunct to a reduced-calorie diet ...

Tags: Belviq, lorcaserin HCl, chronic weight management, Arena Pharmaceuticals